U.S. flag

An official website of the United States government

Format
Sort by

Send to:

Choose Destination

Search results

Items: 5

1.

Letrozole (Femara) early and late responses to treatment

(Submitter supplied) In the present investigation, we have exploited the opportunity provided by neoadjuvant treatment of a group of postmenopausal women with large operable or locally advanced breast cancer (in which therapy is given with the primary tumour remaining within the breast) to take sequential biopsies of the same cancers before and after 10-14 days or 90 days treatment with letrozole. RNA extracted from the biopsies has been subjected to Affymetrix microarray analysis and the data from paired biopsies interrogated to discover genes whose expression is most influenced by oestrogen deprivation. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
176 Samples
Download data: CEL
Series
Accession:
GSE20181
ID:
200020181
2.

Letrozole (Femara) early response to treatment

(Submitter supplied) In the present investigation, we have exploited the opportunity provided by neoadjuvant treatment of a group of postmenopausal women with large operable or locally advanced breast cancer (in which therapy is given with the primary tumour remaining within the breast) to take sequential biopsies of the same cancers before and after 10-14 days treatment with letrozole. RNA extracted from the biopsies has been subjected to Affymetrix microarray analysis and the data from paired biopsies interrogated to discover genes whose expression is most influenced by oestrogen deprivation. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS3116
Platform:
GPL96
116 Samples
Download data: CEL
Series
Accession:
GSE5462
ID:
200005462
3.
Full record GDS3116

Letrozole effect on breast cancer tumors

Analysis of breast cancer tumors following treatment with letrozole for 14 days. The aromatase inhibitor letrozole is an anti-estrogen drug used to treat postmenopausal women with breast cancer. Results provide insight into the molecular mechanism of action of letrozole in breast cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 agent, 58 individual sets
Platform:
GPL96
Series:
GSE5462
116 Samples
Download data: CEL
4.

[HG-U133A] Affymetrix Human Genome U133A Array

(Submitter supplied) Affymetrix submissions are typically submitted to GEO using the GEOarchive method described at http://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/projects/geo/info/geo_affy.html June 03, 2009: annotation table updated with netaffx build 28 June 08, 2012: annotation table updated with netaffx build 32 June 24, 2016: annotation table updated with netaffx build 35 Protocol: see manufacturer's web site The U133 set includes 2 arrays with a total of 44928 entries and was indexed 29-Jan-2002. more...
Organism:
Homo sapiens
364 DataSets
1125 Series
11 Related Platforms
42430 Samples
Download data
Platform
Accession:
GPL96
ID:
100000096
5.

68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder

Organism:
Homo sapiens
Source name:
68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days
Platform:
GPL96
Series:
GSE5462 GSE20181
Dataset:
GDS3116
Download data: CEL
Sample
Accession:
GSM125230
ID:
300125230
Format
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=GSM125230[Accession]|query=1|qty=2|blobid=MCID_665aa4b96c0535498959f12b|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center